FORENSIC DRUG-TESTING FOR OPIATES .2. METABOLISM AND EXCRETION RATE OF MORPHINE IN HUMANS AFTER MORPHINE ADMINISTRATION

被引:34
作者
MITCHELL, JM
PAUL, BD
WELCH, P
CONE, EJ
机构
[1] NIDA,ADDICT RES CTR,POB 5180,BALTIMORE,MD 21224
[2] USN,DRUG SCREENING LAB,NORFOLK,VA 23511
关键词
D O I
10.1093/jat/15.2.49
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Urine levels of free and total morphine were determined by GC/MS for four male subjects who received single doses of 20 mg of morphine sulfate intramuscularly. Peak concentrations were observed within 10 h for both conjugated and free morphine; thereafter, levels declined rapidly. Initially, free morphine represented from 25 to 34% of the total amount of morphine present, but this ratio declined after 12 h to an average of only 5.9% of total morphine. Free morphine accounted for an overall mean of 6.8% of the dose excreted in urine and conjugated morphine for 58.6%. The mean excretion half-life for free morphine was 6.6 h and for conjugated morphine was 8.2 h. The lower concentration and shorter half-life of free morphine resulted in a shorter detection time for free morphine versus total morphine at a 300-ng/mL cutoff. An equivalent detection time for free morphine was obtained when its cutoff was lowered to 25 ng/mL. The possibility that morphine is metabolized to codeine was unequivocally ruled out by the finding of an absence of codeine at or above the LOD of the GC/MS assay in all clinical specimens collected after morphine administration.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 19 条
  • [1] ABRAMS LS, 1974, J PHARMACOL EXP THER, V189, P285
  • [2] BASELT RC, 1982, DISPOSITION TOXIC DR, P536
  • [3] FORMATION OF NORCODEINE FROM MORPHINE IN MAN
    BOERNER, U
    ROE, RL
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (03) : 215 - 216
  • [4] BORNER U, 1973, EXPERIENTIA, V29, P180
  • [5] BRUNK SF, 1974, CLIN PHARMACOL THER, V16, P51
  • [6] CONE EJ, 1989, J FORENSIC SCI, V34, P15
  • [7] CONE EJ, 1990, J ANAL TOXICOL, V15, P1
  • [8] ELISON C, 1964, J PHARMACOL EXP THER, V144, P265
  • [9] GIBALDI M, 1975, PHARMACOKINETICS, V1
  • [10] Jaffe J. H, 1985, PHARMACOL BASIS THER, P491